Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Abbott Cholesterol Drug Subject of False-Marketing Suit
Aug. 23, 2012
A former Abbott Laboratories saleswoman has filed a federal lawsuit against the company, accusing it of illegally promoting its cholesterol drug TriCor for uses not approved by regulators, including the prevention of cardiac health risks in patients with diabetes.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing